Katsuki Haraoka

643 citations
25 papers · 459 indexed · h-index 15
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers)Alzheimer's disease research and treatments (7 papers)Hepatitis C virus research (4 papers)
Partner nations
JapanSwedenIndia

In The Last Decade

Katsuki Haraoka

24 papers receiving 450 citations

Peers

Katsuki Haraoka
Comparison fields: 5 of 76
  • Molecular Biology 359
  • Physiology 122
  • Cell Biology 66
  • Epidemiology 56
  • Genetics 56
Replace M Nakazato with:
M Nakazato Japan
Andrea Grund Germany
F Buck United States
M. Marini Italy
Laura J. Zitur United States
Namiki Ueda Japan
T. Tataranni Italy
Marta Fierro‐Fernández Spain
Yu-Hsia Kuo Taiwan
Marcus Alexandre Mendes Luz Brazil
Katsuki Haraoka relative to M Nakazato Japan M Nakazato's profile →
Citations per field
00.5×1.5×
M Nakazato · 1×
Citations per year

Countries citing papers authored by Katsuki Haraoka

Since Specialization
Citations

This map shows the geographic impact of Katsuki Haraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuki Haraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuki Haraoka more than expected).

Fields of papers citing papers by Katsuki Haraoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuki Haraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuki Haraoka. The network helps show where Katsuki Haraoka may publish in the future.

Co-authorship network of co-authors of Katsuki Haraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuki Haraoka. A scholar is included among the top collaborators of Katsuki Haraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuki Haraoka. Katsuki Haraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 1
3 3
4 13
5 22
6 0
7 7
8 39
9 76
10 16
11 19
12 7
13 17
14 12
15 22
16 30
17 29
18 25
19 14
20 38

About Katsuki Haraoka

Katsuki Haraoka is a scholar working on Hepatology, Physiology and Epidemiology, having authored 25 papers that have together received 459 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Alzheimer's disease research and treatments (7 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Nephrology (48 citations), Hepatology (47 citations) and Molecular Biology (359 citations). Katsuki Haraoka has collaborated with scholars based in Japan, Sweden and India. Frequent co-authors include Yukio Ando, Masaaki Nakamura, Hisayasu Terazaki, Mitsuharu Ueda, Taro Yamashita, Hiroaki Okabe, Xuguo Sun, Hidenobu Tanihara, Makoto Uchino and Eiko Ando. Their work appears in journals such as Journal of Molecular Biology, Neurology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026